Trade Replimune - REPL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023429% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001207% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 8.67 |
| Open | 8.97 |
| 1-Year Change | 40.16% |
| Day's Range | 8.79 - 9.21 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 22, 2025 | 8.67 | -0.05 | -0.57% | 8.72 | 8.93 | 8.38 |
| Apr 21, 2025 | 8.72 | 1.15 | 15.19% | 7.57 | 9.28 | 7.57 |
| Apr 17, 2025 | 7.95 | 0.48 | 6.43% | 7.47 | 7.95 | 7.47 |
| Apr 16, 2025 | 7.59 | 0.10 | 1.34% | 7.49 | 7.83 | 7.47 |
| Apr 15, 2025 | 7.67 | 0.48 | 6.68% | 7.19 | 7.89 | 7.19 |
| Apr 14, 2025 | 7.46 | 0.11 | 1.50% | 7.35 | 7.50 | 7.20 |
| Apr 11, 2025 | 7.30 | 0.41 | 5.95% | 6.89 | 7.32 | 6.83 |
| Apr 10, 2025 | 6.88 | -0.27 | -3.78% | 7.15 | 7.28 | 6.65 |
| Apr 9, 2025 | 7.26 | 0.39 | 5.68% | 6.87 | 7.75 | 6.39 |
| Apr 8, 2025 | 7.10 | -0.47 | -6.21% | 7.57 | 7.93 | 6.98 |
| Apr 7, 2025 | 7.45 | 0.34 | 4.78% | 7.11 | 7.70 | 6.76 |
| Apr 4, 2025 | 7.41 | -0.26 | -3.39% | 7.67 | 7.70 | 7.14 |
| Apr 3, 2025 | 7.85 | -0.48 | -5.76% | 8.33 | 8.33 | 7.82 |
| Apr 2, 2025 | 8.57 | 0.23 | 2.76% | 8.34 | 9.11 | 8.08 |
| Apr 1, 2025 | 8.34 | -1.18 | -12.39% | 9.52 | 9.52 | 8.32 |
| Mar 31, 2025 | 9.71 | -0.30 | -3.00% | 10.01 | 10.01 | 9.55 |
| Mar 28, 2025 | 10.34 | 0.02 | 0.19% | 10.32 | 10.39 | 10.02 |
| Mar 27, 2025 | 10.40 | 0.14 | 1.36% | 10.26 | 10.66 | 10.26 |
| Mar 26, 2025 | 10.37 | -0.01 | -0.10% | 10.38 | 10.62 | 10.12 |
| Mar 25, 2025 | 10.65 | -0.32 | -2.92% | 10.97 | 10.97 | 10.39 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Replimune Company profile
About Replimune Group Inc
Replimune Group, Inc. is a clinical-stage biotechnology company. The Company is engaged in the field of oncolytic immunotherapy to treat the cancer patients. The Company applies its Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The Company is focused on developing a pipeline of oncolytic immunotherapy product candidates to provide clinical benefits to cancer patients. Its product candidates include RP1 (vusolimogene oderparepvec), RP2, and RP3. The Company is focused on Phase 2 clinical trials with its lead product candidate, RP1, in approximately 240 patients with a range of solid tumors.
Financial summary
BRIEF: For the nine months ended 31 December 2021, Replimune Group Inc revenues was not reported. Net loss increased 45% to $86.3M. Higher net loss reflects Research and development increase of 41% to $49.7M (expense), Stock-based Compensation in SGA increase from $4.6M to $12M (expense), General and administrative increase of 38% to $16.1M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.34 to -$1.66.
| Industry: | Biotechnology & Medical Research (NEC) |
500 Unicorn Park Dr
WOBURN
MASSACHUSETTS 01801-3377
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com